Invest Now
Samco Star Rating Ads

Arvee Laboratories (India) Ltd Price Performance

  • Day's Low
  • ₹184.34
  • Day's High
  • ₹193
₹ 185.5
  • 52-w low
  • ₹117.05
  • 52-w high
  • ₹315
185.5
  • Day's open
    ₹187
  • Previous close
    ₹194.050003
  • VWAP
    ₹186.59
  • Lower price band
    ₹184.34
  • Upper price band
    ₹203.75

Today's Market Action

The last traded share price of Arvee Laboratories (India) Ltd was 185.50 down by -4.41% on the NSE. The total volume of shares on NSE and BSE combined was 7,840 shares. Its total combined turnover was Rs 0.15 crores.

Arvee Laboratories (India) Ltd Medium and Long Term Market Action

Arvee Laboratories (India) Ltd hit a 52-week high of 315 on 12-04-2024 and a 52-week low of 117.05 on 21-03-2024. The stock price of Arvee Laboratories (India) Ltd is up by 14% over the last one month. It is up by 8.35% over the last one year. Don't forget to check the full stock price history in the table below.

Arvee Laboratories (India) Ltd Fundamentals

  • Market Cap (Cr): 182

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Arvee Laboratories (India) Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Arvee Laboratories (India) Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Arvee Laboratories (India) Ltd

Data not available.

Arvee Laboratories (India) Ltd FAQ's

What is Share Price of Arvee Laboratories (India) Ltd?

What is the Market Cap of Arvee Laboratories (India) Ltd?

What is PE Ratio of Arvee Laboratories (India) Ltd?

What is PB Ratio of Arvee Laboratories (India) Ltd?

What is the CAGR of Arvee Laboratories (India) Ltd?

How to Buy Arvee Laboratories (India) Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 102.23% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.03. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
  • Above Average Growth Rate
    The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 138 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(19/12/2024)
Stock Valuation
Green line
99
100.00%
100.00% People are bullish about Arvee Laboratories (India) Ltd
0.00%
0.00 % People are bearish about Arvee Laboratories (India) Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Arvee Laboratories (India) Ltd

185.50 -8.55 (-4.41%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91